Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorUniversity of Pittsburgh
About this trial
The purpose of the RISE study is to examine how the 24-hour rhythm of sleep and social activity relate to mood and suicidal ideation among older adults that recently lost a spouse or life partner.
Eligibility criteria
Qualifiers
Bereaved < or = to 12 months from spousal/partner loss
> or = to 65 years old
Verified history of suicide attempt/attempts and/or current or past history of Major Depressive Disorder/Major Depressive Episode (MDD/MDE) (without psychotic features), or history of depression severe enough to trigger treatment, or current subsyndromal depression (> or = to 9 HDRS)
No diagnosis of schizophrenia/schizoaffective disorders/bipolar/current psychosis
Disqualifiers
Bereaved >12 months from spousal/partner bereavement
< 65 years old
Patient is not spousal/partner bereaved (ex: parent, sibling, etc.)
Prior diagnosis of schizophrenia/schizoaffective disorders/bipolar/current psychosis or medications listed indicate diagnosis of these disorders/MDD or MDE with psychotic features
Trial design
Treatments tested in this trial
- WELL Behavioral Probe
Treatment groups
169 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Pittsburgh
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov